Back
Structure Therapeutics Stock Price Chart
Sponsored
GPCR
Sponsored
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!
Buy
71
GPCR
Structure Therapeutics
Last Price:
41.65
Seasonality Move:
4.68%
7 Day Trial
ALL ACCESS PASS
$
7
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More- The current trend is moderately bullish and GPCR is experiencing slight buying pressure.
Structure Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.32 | Buy |
20-day SMA: | 39.44 | Buy |
50-day SMA: | 38.13 | Buy |
200-day SMA: | 40.73 | Buy |
8-day EMA: | 41.37 | Buy |
20-day EMA: | 40.15 | Buy |
50-day EMA: | 39.42 | Buy |
200-day EMA: | 39.76 | Buy |
Structure Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.05 | Buy |
Relative Strength Index (14 RSI): | 56.84 | Buy |
Chaikin Money Flow: | 9293 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.34 - 41.7) | Buy |
Bollinger Bands (100): | (34.82 - 45.26) | Buy |
Structure Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 41.75 while GPCR 8-day simple moving average is 41.32, which is a Buy signal.
- The stock price of GPCR is 41.75 while Structure Therapeutics 20-day SMA is 39.44, which makes it a Buy.
- Structure Therapeutics 50-day simple moving average is 38.13 while GPCR share price is 41.75, making it a Buy technically.
- GPCR stock price is 41.75 and Structure Therapeutics 200-day simple moving average is 40.73, creating a Buy signal.
GPCR Technical Analysis vs Fundamental Analysis
Buy
71
Structure Therapeutics (GPCR)
is a Buy
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a Buy
The current Structure Therapeutics [GPCR] share price is $41.75. The Score for GPCR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Structure Therapeutics Stock Info
Market Cap:
2.39B
Price in USD:
41.75
Share Volume:
506.38K
Structure Therapeutics 52-Week Range
52-Week High:
75.02
52-Week Low:
26.61
Buy
71
Structure Therapeutics (GPCR)
is a Buy
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?
The Structure Therapeutics stock price is 41.75 USD today. -
Will GPCR stock go up or go down?
Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Structure Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is not overvalued.
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 41.75 while GPCR 8-day exponential moving average is 41.37, which is a Buy signal.
- The stock price of GPCR is 41.75 while Structure Therapeutics 20-day EMA is 40.15, which makes it a Buy.
- Structure Therapeutics 50-day exponential moving average is 39.42 while GPCR share price is 41.75, making it a Buy technically.
- GPCR stock price is 41.75 and Structure Therapeutics 200-day simple moving average is 39.76, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
- GPCR Moving Average Covergence Divergence (MACD) indicator is 1.05, suggesting Structure Therapeutics is a Buy
- Structure Therapeutics Relative Strength Index (RSI) is 56.84, which suggest Structure Therapeutics is overbought
- The Bollinger Bands (25) for Structure Therapeutics is (37.34 - 41.7), which suggest Structure Therapeutics is a Buy
- The Bollinger Bands (100) for Structure Therapeutics is (34.82 - 45.26), which suggest Structure Therapeutics is a Buy
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.